title: [Effect of type 1 sphingosine-1-phosphate receptor siRNA on human salivary gland cells].
abstract: To construct sphingosine 1-phosphate receptor-1 (S1P1)-small interfering RNA (siRNA) lentiviral vectors and infect human salivary gland cells (HSG), and to investigate its possible therapy on Sjogren's syndrome.
  
  
  
  HSG cells were divided into blank group, empty vector group, scramble-siRNA group and S1P1-siRNA group. The lentiviral vectors expressing siRNA against S1P1 and the pLL3.7 were respectively transfected into 293T cells with pMD2.G, pMDL g/p RRE, pRSV-REV to produce virus, and then infect HSG cells. The efficiency was observed by flow cytometry after the transfection for 48 h. The expression levels of S1P1 mRNA of HSG were detected by real-time RT-PCR and the expression of S1P1 protein was detected by immunohistochemistry method. The expression levels of interferon-γ (IFN-γ) and interleukin (IL)-17 in the supernatant of the cells were detected by ELISA method.
  
  
  
  (1) The scramble-siRNA, S1P1-siRNA lentiviral vector was successfully constructed, and the lentivirus titer was about 3.5×108TU/mL. (2) The level of S1P1 mRNA was lower in S1P1-siRNA group than those in the blank group, empty vector group, and scramble-siRNA group 48 h after infection, there were significant differences between them (P<0.05). (3) The expression of S1P1 protein was lower in S1P1-siRNA group than those in blank group, empty vector group, and scramble-siRNA group 48 h after transfection, there were significant differences between them (P<0.05). (4) The levels of IL-17 were lower in S1P1-siRNA group than those in blank group, empty vector group, and scramble-siRNA group 48 h after transfection, there were significant differences between them (P<0.05). (5) The levels of IFN-γ in S1P1-siRNA group were lower than those in blank group, empty vector group, and scramble-siRNA group 48 h after transfection, there were significant differences between them (P<0.05).
  
  
  
  The lentiviral vector targeting S1P1 was successfully constructed. S1P1 siRNA could suppress the levels of S1P1 mRNA and protein, and decrease the expression of IL-17 and IFN-γ. S1P1 siRNA could infect HSG cells stably and inhibit the expression of S1P1 gene specifically and efficiently, and reduce the levels of inflammatory cytokines.
authors.affiliation: Department of Rheumatology, the Fist Affiliated Hospital of Baotou Medical College, Baotou 014010, Inner Mongolia Autonomous Region, China.
authors.forename: Q
authors.initials: Q
authors.lastname: Li
authors.affiliation: Department of Rheumatology, the Fist Affiliated Hospital of Baotou Medical College, Baotou 014010, Inner Mongolia Autonomous Region, China.
authors.forename: Z F
authors.initials: ZF
authors.lastname: Chang
authors.affiliation: Key Autoimmunity Lab of Inner Mongolia Autonomous Region, Baotou 014010, Inner Mongolia Autonomous Region, China.
authors.forename: G A
authors.initials: GA
authors.lastname: Yang
authors.affiliation: Department of Rheumatology, the Fist Affiliated Hospital of Baotou Medical College, Baotou 014010, Inner Mongolia Autonomous Region, China;Key Autoimmunity Lab of Inner Mongolia Autonomous Region, Baotou 014010, Inner Mongolia Autonomous Region, China.
authors.forename: C Y
authors.initials: CY
authors.lastname: Pang
authors.affiliation: Department of Rheumatology, the Fist Affiliated Hospital of Baotou Medical College, Baotou 014010, Inner Mongolia Autonomous Region, China;Key Autoimmunity Lab of Inner Mongolia Autonomous Region, Baotou 014010, Inner Mongolia Autonomous Region, China.
authors.forename: Y F
authors.initials: YF
authors.lastname: Wang
mesh_terms: D016207:Cytokines; D005786:Gene Expression Regulation / Q000187:drug effects*; D005822:Genetic Vectors / Q000008:administration & dosage / Q000096:biosynthesis / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques / Q000379:methods; D007371:Interferon-gamma / Q000187:drug effects / Q000235:genetics; D020381:Interleukin-17 / Q000235:genetics; D016086:Lentivirus; D012333:RNA, Messenger; D034741:RNA, Small Interfering / Q000096:biosynthesis* / Q000494:pharmacology*; D049349:Receptors, Lysosphingolipid / Q000187:drug effects* / Q000235:genetics* / Q000502:physiology*; D012469:Salivary Glands / Q000187:drug effects; D014162:Transfection / Q000379:methods*
chemical_list: D016207:Cytokines; C508717:IL17A protein, human; D020381:Interleukin-17; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D049349:Receptors, Lysosphingolipid; D007371:Interferon-gamma